Cargando…

Different Responses of Neointimal Cells to Imatinib Mesylate and Rapamycin Compared with Normal Vascular Smooth Muscle Cells

PURPOSE: This study was designed to investigate whether vascular smooth muscle cells (VSMC) from the neointima showed any different response to anti-proliferative agents, such as rapamycin or imatinib mesylate, compared to VSMCs from normal artery. MATERIALS AND METHODS: Intimal hyperplasia was made...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Yang Jin, Min, Sang-Il, Jung, In Mok, Lee, Taeseung, Ha, Jongwon, Chung, Jung Kee, Kim, Sang Joon, Min, Seung-Kee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Vascular Specialist International 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480304/ https://www.ncbi.nlm.nih.gov/pubmed/26217609 http://dx.doi.org/10.5758/vsi.2014.30.1.5

Ejemplares similares

Effect of imatinib mesylate and rapamycin on the preformed intimal hyperplasia in rat carotid injury model
por: Park, Yang Jin, et al.
Publicado: (2015)

Inhibition of intimal hyperplasia by local perivascular application of rapamycin and imatinib mesilate after carotid balloon injury
por: Park, Daedo, et al.
Publicado: (2013)

Expression of Cell Cycle Regulators During Smooth Muscle Cell Proliferation After Balloon Catheter Injury of Rat Artery
por: Chung, Jung Kee, et al.
Publicado: (2004)

Limited Feasibility in Endovascular Aneurysm Repair Using Currently Available Graft in Korea
por: Bae, Taeseok, et al.
Publicado: (2008)

Validation of the Korean version of the walking impairment questionnaire in patients with peripheral arterial disease
por: Choi, Chanjoong, et al.
Publicado: (2017)

Inadvertent vascular injury of the aorta or vena cava caused by acupuncture
por: Choi, Chanjoong, et al.
Publicado: (2015)

Current Status of the Retrieval Rate of Retrievable Vena Cava Filters in a Tertiary Referral Center in Korea
por: Park, Hyeongmin, et al.
Publicado: (2014)

Imatinib Mesylate-Induced Hyperpigmentation of the Nose and Palate
por: Song, Hyo Sang, et al.
Publicado: (2014)

Mig-6 Gene Knockout Induces Neointimal Hyperplasia in the Vascular Smooth Muscle Cell
por: Lee, Ju Hee, et al.
Publicado: (2014)

Iliofemoral vein thrombosis due to an intravascular fasciitis
por: Min, Sang-il, et al.
Publicado: (2015)

Exacerbation of Psoriasis after Imatinib Mesylate Treatment
por: Shim, Joon Ho, et al.
Publicado: (2016)

Chronological Change of the Sac after Endovascular Aneurysm Repair
por: Kim, Min Hyun, et al.
Publicado: (2016)

Plantar Keratoderma with Pachyonychia Likely Induced by Imatinib Mesylate
por: Kim, Hyung Ok, et al.
Publicado: (2013)

Periorbital edema secondary to imatinib mesylate
por: McClelland, Collin M, et al.
Publicado: (2010)

Cutaneous adverse effects of imatinib mesylate
por: Dogu, Mehmet Hilmi, et al.
Publicado: (2015)

Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia
por: Ko, Dai Sik, et al.
Publicado: (2022)

Successful Rechallenge with Imatinib in a Patient with Chronic Myeloid Leukemia Who Previously Experienced Imatinib Mesylate Induced Pneumonitis
por: Go, Seong Woo, et al.
Publicado: (2013)

Imatinib Mesylate plus Hydroxyurea Chemotherapy for Cerebellar Meningioma in a Belgian Malinois Dog
por: JUNG, Hae-Won, et al.
Publicado: (2014)

Wood-Derived Vascular Patches Loaded With Rapamycin Inhibit Neointimal Hyperplasia
por: Xie, Boao, et al.
Publicado: (2022)

Imatinib mesylate resistance and mutations: An Indian experience
por: Srivastava, Shweta, et al.
Publicado: (2013)

Lichenoid drug eruption due to imatinib mesylate
por: Bhatia, Anuradha, et al.
Publicado: (2015)

The teratogenic effects of imatinib mesylate on rat fetuses
por: El Gendy, M.M., et al.
Publicado: (2015)

Imatinib Mesylate-Induced Erythema Multiforme: Recurrence after Rechallenge with 200 mg/day Imatinib
por: Lee, Min Kyung, et al.
Publicado: (2015)

In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells
por: Weigel, Marion T, et al.
Publicado: (2010)

Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)
por: Cho, Ah Young, et al.
Publicado: (2011)

Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate
por: Din, Omar S, et al.
Publicado: (2008)

The role of c-kit and imatinib mesylate in uveal melanoma
por: Pereira, Patricia Rusa, et al.
Publicado: (2005)

Ageing is a risk factor in imatinib mesylate cardiotoxicity
por: Maharsy, Wael, et al.
Publicado: (2014)

Molecular Mobility and Stability Studies of Amorphous Imatinib Mesylate
por: Karolewicz, Bożena, et al.
Publicado: (2019)

Safety, tolerability, and pharmacokinetics of single and multiple topical ophthalmic administration of imatinib mesylate in healthy subjects
por: Na, Joo Young, et al.
Publicado: (2022)

Lichenoid Drug Eruption after Low-Dose Imatinib Mesylate Treatment
por: Lee, Jae-Hyung, et al.
Publicado: (2013)

Phase I clinical trial combining imatinib mesylate and IL-2 in refractory cancer patients: IL-2 interferes with the pharmacokinetics of imatinib mesylate
por: Pautier, Patricia, et al.
Publicado: (2013)

Covalent modification of pericardial patches for sustained rapamycin delivery inhibits venous neointimal hyperplasia
por: Bai, Hualong, et al.
Publicado: (2017)

Viscolin Inhibits In Vitro Smooth Muscle Cell Proliferation and Migration and Neointimal Hyperplasia In Vivo
por: Chen, Chin-Chuan, et al.
Publicado: (2016)

Concurrent Male Gynecomastia and Testicular Hydrocele after Imatinib Mesylate Treatment of a Gastrointestinal Stromal Tumor
por: Kim, Hawk, et al.
Publicado: (2005)

Comparison of Costs of Endovascular Repair versus Open Surgical Repair for Abdominal Aortic Aneurysm in Korea
por: Min, Sang Il, et al.
Publicado: (2012)

Early Sustained Injections of Erythropoietin Improve Angiogenesis and Restoration of Perfusion in the Ischemic Mouse Hindlimb
por: Ahn, Sanghyun, et al.
Publicado: (2012)

Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia
por: Oh, Hyun Jin, et al.
Publicado: (2013)

Combined application of rapamycin and atorvastatin improves lipid metabolism in apolipoprotein E-deficient mice with chronic kidney disease
por: Song, Eun Ju, et al.
Publicado: (2021)

Surgical Treatment of Infected Aortoiliac Aneurysm
por: Youn, Joong Kee, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_51n1vu30k2q2ji7pk5vjpegcuu